2219.HK CHAOJU EYE CARE

Healthcare · Medical Care Facilities

5 · Fair Momentum 2.0 · Weak At risk

2.54

-1.17%

About the company

Chaoju Eye Care Holdings Limited, together with its subsidiaries, owns and operates a network of ophthalmic hospitals and centers in the People's Republic of China. The company offers in-patient and out-patient ophthalmic medical services; and consumer ophthalmic services, including treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia prevention and control. It also provides basic ophthalmic services for the treatment of a range of eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, dry eye syndrome, and oculoplastic and pediatric eye diseases. In addition, the company engages in investment management activities; and the sale of equipment, optical products, and medical consumables. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.

Website

—

1.8B

8.48

0.30

2.65

52-week range

2.54

low 2.20 high 3.14

Dividend deep dive

CHAOJU EYE CARE (2219.HK) operates in the Medical Care Facilities industry within the Healthcare sector. The company currently offers a dividend yield of 9.25%. This yield is above its 5-year high of 6.58%, suggesting it is undervalued by yield theory. The company has an overall rating score of 8.0, with a momentum score of 4.0, indicating a weaker price trend. Its value score stands at 6.7.

Dividend history

CHAOJU EYE CARE has not established a streak of consecutive dividend increases, with a streak of 0 years. The 3-year dividend CAGR is 4.58%, while the 5-year CAGR information is not available. The company's dividend history shows per-share dividends of 0.1043 HKD in 2022, 0.1738 HKD in 2023, and 0.2141 HKD in 2024. The projected dividend for 2025 is 0.1193 HKD, which represents a decrease from the prior year. Payments are typically made semi-annually in May, June, and September.

Dividend safety

The dividend safety status for CHAOJU EYE CARE is currently "at_risk". The company's payout ratio stands at 80.0% of its earnings per share, indicating a significant portion of earnings is distributed as dividends.

Quantic · Free

Read the rest of the safety verdict

Plus the key risks and what to watch next — free, no card.

Try a sample portfolio Sign up free

AI-generated from Quantic's dividend data · Updated 17 Aug 2026 · Information, not financial advice.